Efficacy and Safety of Twice-Yearly Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): The Phase III Randomized, Double-Blind, Placebo-Controlled Replicate ANCHOR-1/2 Trials Meeting Abstract

publication date

  • February 1, 2025

webpage

published in

start page

  • AB443

end page

  • AB443

volume

  • 155

issue

  • 2